Aztreonam 1gm Injection in PCD pharma franchise in Hyderabad

Aztreonam 1gm Injection in pharmaceutical manufacturing company in Mumbai

Aztreonam 1gm Injection in antibiotic pharma franchise in Pune

Aztreonam 1gm Injection in pharma suppliers in Delhi

Aztreonam 1gm Injection in pharma export companies in Kolkata
Aztreonam 1gm Injection in pharma franchise opportunities in Bengaluru

Home/Products /aztreonam-1gm-injection

Aztrip 1 Injection

Composition : Aztreonam 1gm Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 1gm

Price : ₹1/-

Aztreonam 1gm Injection is a monobactam antibiotic formulated to combat serious gram-negative bacterial infections. It specifically targets and inhibits bacterial cell wall synthesis, resulting in bactericidal activity. Unlike penicillins and cephalosporins, Aztreonam has minimal cross-reactivity, making it a safer option for patients with β-lactam allergies. It is particularly effective against Enterobacteriaceae, Pseudomonas aeruginosa, and other resistant gram-negative pathogens.

Read More

About the Product

Aztreonam 1gm Injection is a monobactam antibiotic formulated to combat serious gram-negative bacterial infections. It specifically targets and inhibits bacterial cell wall synthesis, resulting in bactericidal activity. Unlike penicillins and cephalosporins, Aztreonam has minimal cross-reactivity, making it a safer option for patients with β-lactam allergies. It is particularly effective against Enterobacteriaceae, Pseudomonas aeruginosa, and other resistant gram-negative pathogens.

Aztreonam 1gm Injection is generally well tolerated. However, some patients may experience local injection site pain, rash, gastrointestinal disturbances (nausea, vomiting, diarrhea), transient liver enzyme elevation, or headache. Rare but serious side effects include hypersensitivity reactions and Clostridium difficile-associated diarrhea.

This injection is used in the treatment of severe systemic infections such as urinary tract infections, lower respiratory tract infections, intra-abdominal infections, gynecological infections, septicemia, and post-operative infections caused by susceptible gram-negative organisms.

This medication should be administered only under medical supervision. Dose adjustment is essential in patients with renal insufficiency. It is not effective against gram-positive or anaerobic organisms and should not be used as monotherapy in mixed infections unless susceptibility is confirmed.

Store in a cool, dry place, below 25°C, protected from light. Use aseptic technique during reconstitution. Reconstituted solution should be used promptly or stored as per manufacturer's instructions. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation